Encompass Health Secures New $1 Billion Credit Facility, Extends Maturity to 2031 with Improved Terms
Summary
Encompass Health Corp has successfully refinanced its credit facility, extending the maturity date to 2031, reducing fees, and enhancing financial flexibility and liquidity with a $1 billion revolving credit facility and a substantial accordion feature.
Key Events
-
New Credit Agreement
Encompass Health Corp entered into a new $1 billion revolving credit facility (the '2026 Credit Agreement') on March 9, 2026.
-
Maturity Extension
The maturity date of the revolving credit facility has been extended from October 7, 2027, to March 9, 2031, significantly improving the company's debt maturity profile.
-
Improved Financial Terms
The new agreement includes a 5 basis point reduction in the commitment fee for the undrawn portion of the revolving loan and eliminates a 0.10% interest adjustment on Term SOFR Borrowings, leading to cost savings.
-
Enhanced Flexibility and Liquidity
The company gained increased financial flexibility through relaxed limitations on investments, debt incurrence, liens, and restricted payments. The swingline loan sublimit was also increased from $25 million to $40 million.
Analysis
This 8-K filing signals a significant positive development for Encompass Health Corp's financial health and operational flexibility. The company has successfully refinanced its primary credit facility, extending its debt maturity profile by over three years to 2031. This extension significantly reduces near-term refinancing risk and provides greater long-term financial stability. Furthermore, the new agreement includes more favorable terms, such as lower commitment fees and relaxed covenants, which enhance the company's ability to pursue strategic investments, incur debt, and make restricted payments. The substantial $1 billion revolving credit facility, coupled with an accordion feature allowing for an additional $1.4 billion (or 100% of Adjusted Consolidated EBITDA), provides ample liquidity and capacity for future growth initiatives. The immediate use of $250 million to repay the old facility demonstrates a smooth transition and prudent financial management. This move is particularly strong following the company's recent positive 2025 financial results, reinforcing investor confidence in its operational performance and strategic direction.
At the time of this filing, EHC was trading at $106.89 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $10.6B. The 52-week trading range was $92.53 to $127.99. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.